Xenetic Biosciences, Inc. (XBIO) Social Stream
XENETIC BIOSCIENCES INC (XBIO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering XBIO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 23, 2023
The Trend in the Analyst Price Target
XBIO's average price target has moved down $1 over the prior 19 months.
XBIO reports an average of 595.52% for its upside potential over the past 47 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XBIO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, XBIO's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, XENETIC BIOSCIENCES INC's number of analysts covering the stock is greater than nearly none of them.
- XENETIC BIOSCIENCES INC's variance in analysts' estimates is lower than almost 100% of all US stocks.
- XBIO has a higher average analyst price target than 11.62% of Healthcare stocks.
- In the context of Healthcare stocks, XENETIC BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 175.42% of them.
Stocks similar to XENETIC BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BNTC, PRFX, and INM.
View All Top Stocks by Price Target
Is XBIO a Buy, Hold or Sell? See the POWR Ratings now!